CME Posttest: Pulmonary arterial hypertension; Chronic lymphocytic leukemia

AAPA members should complete and submit posttests on the AAPA Web site by going to www.aapa.org and searching for keyword JAAPA post-tests. All others may complete and submit posttests online at no charge at www.mycme.com. To obtain 1 hour of AAPA Category I CME credit, PAs must receive a score of 70% or better on each test taken.

PULMONARY ARTERIAL HYPERTENSION


1. In the Dana Point classification of pulmonary hypertension, PH due to left heart disease belongs to


a. Group 1

b. Group 2

c. Group 3

d. Group 4


2. The primary treatment for patients with group 3 
pulmonary hypertension is


a. Oxygen

b. Oral anticoagulants

c. Calcium channel blockers

d. Phosphodiesterase type 5 inhibitors


3. Pulmonary hypertension is seen in up to 40% of 
patients with


a. Connective tissue disease

b. Cirrhosis

c. Thyroid dysfunction

d. Chronic kidney disease


4. The most frequent presenting complaint in patients 
with pulmonary arterial hypertension (PAH) is


a. Leg edema

b. Chest pain

c. Near syncope

d. Dyspnea on exertion


5. The most important initial study in the evaluation 
of PAH is


a. Pulmonary function testing

b. Echocardiography

c. Electrocardiography

d. Chest radiography


6. Bosentan may reduce the efficacy of


a. Oral contraceptives

b. ACE inhibitors

c. Protease inhibitors

d. Tricyclic antidepressants


CHRONIC LYMPHOCYTIC LEUKEMIA

7. In chronic lymphocytic leukemia (CLL), a characteristic finding on the peripheral blood smear is


a. Pancytopenia

b. Auer rods

c. Smudge cells

d. Leukocytosis 


8. Patients are considered to have small lymphocytic 
lymphoma if they present with


a. Rapidly doubling lymphocytosis

b. Lymphadenopathy/splenomegaly alone

c. Pancytopenia with circulating blasts

d. Hypercellular bone marrow with left shift


9. Patients with hypogammaglobulinemia, the most 
common intrinsic immune defect, are predisposed to infections, most of which involve the 


a. Respiratory tract

b. Urinary tract

c. Skin

d. Central nervous system


10. Indications for therapy for CLL include signs and 
symptoms directly related to progressive accumulation of neoplastic CLL cells in the blood, such as


a. Engorged retinal veins

b. Severe bone pain

c. Gingival hyperplasia

d. Bulky adenopathy


11. The most widely used therapy for CLL is


a. Cyclophosphamide

b. Chlorambucil

c. Fludarabine

d. Rituximab


12. Patients with CLL should avoid being vaccinated against 


a. Pertussis

b. Influenza

c. Tetanus

d. Herpes zoster


CME EXPIRATION DATE: MAY 2012